Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
45,000
-13.94%
|
$1,845,000
$41.76 P/Share
|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+12.23%
|
$405,000
$9.65 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
SELL
Open market or private sale
|
Direct |
26,468
-28.06%
|
$1,085,188
$41.33 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,468
+20.75%
|
$105,872
$4.74 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
30,996
-51.49%
|
$1,239,840
$40.0 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,996
+33.24%
|
$309,960
$10.07 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
8,503
-39.08%
|
$340,120
$40.0 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,503
+28.1%
|
$42,515
$5.88 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.13%
|
$850,000
$34.89 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.42%
|
$150,000
$6.0 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$175,000
$35.8 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.35%
|
$30,000
$6.0 P/Share
|
|
Oct 19
2021
|
Ching Jaw SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
35,687
-40.21%
|
$1,249,045
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
10,332
-45.53%
|
$361,620
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,332
+30.34%
|
$61,992
$6.72 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
SELL
Open market or private sale
|
Direct |
19,979
-28.21%
|
$699,265
$35.74 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,979
+22.0%
|
$139,853
$7.03 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$185,000
$37.74 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.0 P/Share
|
|
Oct 14
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.31%
|
$74,000
$37.73 P/Share
|
|
Oct 01
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+2.54%
|
$5,508
$36.74 P/Share
|
|
Oct 01
2021
|
L Patrick Gage Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+1.73%
|
$18,360
$36.74 P/Share
|
|
Oct 01
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+2.26%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+2.54%
|
$5,508
$36.74 P/Share
|
|
Oct 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
7,569
-5.23%
|
$264,915
$35.14 P/Share
|
|
Sep 30
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$170,000
$34.01 P/Share
|
|
Sep 30
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.0 P/Share
|
|
Sep 15
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.69%
|
$160,000
$32.66 P/Share
|
|
Sep 15
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.69%
|
$30,000
$6.15 P/Share
|
|
Sep 09
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.29%
|
$62,000
$31.43 P/Share
|
|
Sep 02
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$165,000
$33.12 P/Share
|
|
Sep 02
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Sep 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
7,850
-5.15%
|
$251,200
$32.78 P/Share
|
|
Aug 18
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$155,000
$31.14 P/Share
|
|
Aug 18
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Aug 12
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.27%
|
$64,000
$32.6 P/Share
|
|
Aug 05
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$145,000
$29.12 P/Share
|
|
Aug 05
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Aug 02
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
2,616
-1.69%
|
$75,864
$29.67 P/Share
|
|
Jul 22
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$145,000
$29.82 P/Share
|
|
Jul 22
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.3 P/Share
|
|
Jul 19
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
11,965
-36.86%
|
$346,985
$29.0 P/Share
|
|
Jul 19
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,965
+26.56%
|
$119,650
$10.68 P/Share
|
|
Jul 08
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.26%
|
$38,000
$19.48 P/Share
|
|
Jul 07
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.54%
|
$589
$19.77 P/Share
|
|
Jul 07
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.97%
|
$1,197
$19.77 P/Share
|
|
Jul 07
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.97%
|
$1,197
$19.77 P/Share
|